PWS

Precision Wealth Strategies Portfolio holdings

AUM $301M
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+21.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$301M
AUM Growth
-$7.24M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
187
New
Increased
Reduced
Closed

Top Buys

1
+$3.68M
2
+$3.44M
3
+$3.37M
4
NEM icon
Newmont
NEM
+$3.18M
5
SCCO icon
Southern Copper
SCCO
+$2.97M

Top Sells

1
+$5.55M
2
+$4.97M
3
+$4.43M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$4.03M
5
HOOD icon
Robinhood
HOOD
+$2.89M

Sector Composition

1 Technology 11.18%
2 Industrials 8.3%
3 Consumer Discretionary 5.17%
4 Healthcare 5.03%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KGC icon
151
Kinross Gold
KGC
$36B
$227K 0.08%
+7,441
XOM icon
152
Exxon Mobil
XOM
$602B
$226K 0.08%
1,333
-395
PG icon
153
Procter & Gamble
PG
$334B
$221K 0.07%
1,531
-365
COST icon
154
Costco
COST
$424B
$218K 0.07%
219
-127
F icon
155
Ford
F
$69.5B
$143K 0.05%
12,412
-50
AGNT
156
eXp World Holdings
AGNT
$808M
$82.7K 0.03%
13,805
ACN icon
157
Accenture
ACN
$115B
– –
-1,350
ADBE icon
158
Adobe
ADBE
$105B
– –
-615
ADT icon
159
ADT
ADT
$5.1B
– –
-67,818
AMSC icon
160
American Superconductor
AMSC
$2.43B
– –
-8,137
AUPH icon
161
Aurinia Pharmaceuticals
AUPH
$1.97B
– –
-54,176
BKNG icon
162
Booking.com
BKNG
$130B
– –
-20,675
BWMN icon
163
Bowman Consulting
BWMN
$552M
– –
-10,934
CYD icon
164
China Yuchai International
CYD
$2.13B
– –
-25,297
CYBR
165
DELISTED
CyberArk
CYBR
– –
-497
EGO icon
166
Eldorado Gold
EGO
$8.81B
– –
-20,558
GILT icon
167
Gilat Satellite Networks
GILT
$1.3B
– –
-85,129
HBM icon
168
Hudbay
HBM
$11.6B
– –
-73,683
MCHB
169
Mechanics Bancorp
MCHB
$3.26B
– –
-45,018
HOOD icon
170
Robinhood
HOOD
$84.9B
– –
-25,540
IFS icon
171
Intercorp Financial Services
IFS
$5.5B
– –
-14,951
IIIN icon
172
Insteel Industries
IIIN
$534M
– –
-12,386
NEXN
173
Nexxen International
NEXN
$468M
– –
-196,002
NKE icon
174
Nike
NKE
$68.5B
– –
-3,413
NVO
175
Novo Nordisk
NVO
$202B
– –
-10,128
4 5 6
7
8